As part of its commitment in the fight against cancer, Royal Bahrain Hospital (RBH) – a 60-bedded multi-specialty hospital based in Salmaniya, is offering a genetic screening test which aims to identify women who are at a very high risk of developing breast (and ovarian) cancer.
Breast cancer is the most common cancer worldwide- in some populations, it is estimated that an alarming 1 in every 8 women (12.5%) will get some form of this cancer.
BRCA gene mutations (harmful changes) are among the causes of breast cancer. In women having mutations in their BRCA genes, up to 90% will go on to develop breast cancer. Mutations in these genes also cause ovarian cancer in 10-40% of women who carry a mutation.
The BRCA gene test offered by RBH is a blood test that uses DNA analysis to identify mutations in BRCA1 and BRCA2 tumor suppressor genes.
“The relatives of a person with breast cancer are strongly advised to undergo this test, since the BRCA gene mutation is inherited. A negative result of the test in families at risk would help relieve anxiety, while a positive result would enable effective measures to be taken, which would almost completely eliminate the risk of developing breast cancer, and to a lesser extent, ovarian cancer, at a later stage,” said, Dr. Anees Sheriff – Pathologist at RBH.
It is worth mentioning that RBH delivers state-of-the-art-medical care with a professional team of doctors, nurses, paramedics and administrators, combined with high-end facilities and equipment from countries such as Germany and the USA.
Furthermore, the hospital has a modern Hospital Information System (HIS), which allows operations to be almost paperless. It provides affordable, safe and competent care to its patients, keeping with the highest international standards.